Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01643577 · ClinicalTrials.gov registry record · Phase 1

Acupuncture Treatment for Gastroparesis: a Pilot Study

A Phase 1 study, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target

NCT01643577: Completed Phase 1 study, sponsored by Johns Hopkins University.

NCT01643577 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01643577, a Phase 1 study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target

Study Summary

Gastroparesis is a disorder characterized by delayed gastric emptying leading to symptoms of nausea, vomiting, bloating, and abdominal pain. A common cause is diabetes but even more often it occurs in otherwise healthy individuals. The symptoms of gastroparesis can significantly alter a patient's quality of life. Current therapies are limited. In this study, the investigators seek to determine if twice weekly acupuncture treatments can improve symptoms of gastroparesis.

Interventions

  • PROCEDURE Acupuncture for gastroparesis
  • PROCEDURE Acupuncture for musculoskeletal pain

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-11
Est. Completion 2013-11
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT01643577

The ClinicalTrials.gov registry entry for NCT01643577 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Acupuncture for gastroparesis is the first listed.

NCT01643577 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01643577 about?

NCT01643577 is a clinical study titled "Acupuncture Treatment for Gastroparesis: a Pilot Study". Gastroparesis is a disorder characterized by delayed gastric emptying leading to symptoms of nausea, vomiting, bloating, and abdominal pain. A common cause is diabetes but even more often it occurs in otherwise healthy individuals. The symptoms of gastroparesis can significantly alter a patient's qu...

What is the current status of trial NCT01643577?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-11. Estimated completion is 2013-11.

What interventions are being tested in trial NCT01643577?

The interventions under investigation include: Acupuncture for gastroparesis (PROCEDURE), Acupuncture for musculoskeletal pain (PROCEDURE).

Who is sponsoring clinical trial NCT01643577?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.